The Construction of a Multidomain Risk Model of Alzheimer's Disease and Related Dementias

被引:2
|
作者
Akushevich, Igor [1 ]
Yashkin, Arseniy [1 ]
Ukraintseva, Svetlana [1 ]
Yashin, Anatoliy I. [1 ]
Kravchenko, Julia [2 ]
机构
[1] Duke Univ, Social Sci Res Inst, Biodemog Aging Res Unit, Durham, NC USA
[2] Duke Univ, Dept Surg, Med Ctr, Durham, NC USA
关键词
Alzheimer's disease; environmental exposure; genetic factors; Medicare; polygenic risk scores; predictive models; risk factors; ATRIAL-FIBRILLATION; COGNITIVE IMPAIRMENT; HUMAN LONGEVITY; SELF-REPORT; FOLLOW-UP; OLDER; PREVALENCE; CANCER; HEALTH; GENES;
D O I
10.3233/JAD-221292
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: Alzheimer's disease (AD) and related dementia (ADRD) risk is affected by multiple dependent risk factors; however, there is no consensus about their relative impact in the development of these disorders. Objective: To rank the effects of potentially dependent risk factors and identify an optimal parsimonious set of measures for predicting AD/ADRD risk from a larger pool of potentially correlated predictors. Methods: We used diagnosis record, survey, and genetic data from the Health and Retirement Study to assess the relative predictive strength of AD/ADRD risk factors spanning several domains: comorbidities, demographics/socioeconomics, health-related behavior, genetics, and environmental exposure. A modified stepwise-AIC-best-subset blanket algorithm was then used to select an optimal set of predictors. Results: The final predictive model was reduced to 10 features for AD and 19 for ADRD; concordance statistics were about 0.85 for one-year and 0.70 for ten-year follow-up. Depression, arterial hypertension, traumatic brain injury, cerebrovascular diseases, and the APOE4 proxy SNP rs769449 had the strongest individual associations with AD/ADRD risk. AD/ADRD risk-related co-morbidities provide predictive power on par with key genetic vulnerabilities. Conclusions: Results confirm the consensus that circulatory diseases are the main comorbidities associated with AD/ADRD risk and show that clinical diagnosis records outperform comparable self-reported measures in predicting AD/ADRD risk. Model construction algorithms combined with modern data allows researchers to conserve power (especially in the study of disparities where disadvantaged groups are often grossly underrepresented) while accounting for a high proportion of AD/ADRD-risk-related population heterogeneity stemming from multiple domains.
引用
收藏
页码:535 / 550
页数:16
相关论文
共 50 条
  • [41] Gut microbial metabolism in Alzheimer's disease and related dementias
    Kang, Jea Woo
    Vemuganti, Vaibhav
    Kuehn, Jessamine F.
    Ulland, Tyler K.
    Rey, Federico E.
    Bendlin, Barbara B.
    NEUROTHERAPEUTICS, 2024, 21 (06)
  • [42] The potential of psychedelics for the treatment of Alzheimer's disease and related dementias
    Winkelman, Michael James
    Szabo, Attila
    Frecska, Ede
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2023, 76 : 3 - 16
  • [43] Cholinesterase inhibitors in the treatment of Alzheimer's disease and related dementias
    Masterman, D
    CLINICS IN GERIATRIC MEDICINE, 2004, 20 (01) : 59 - +
  • [44] Recommendations of the Alzheimer's Disease-Related Dementias Conference
    Montine, Thomas J.
    Koroshetz, Walter J.
    Babcock, Debra
    Dickson, Dennis W.
    Galpern, Wendy R.
    Glymour, M. Maria
    Greenberg, Steven M.
    Hutton, Michael L.
    Knopman, David S.
    Kuzmichev, Andrey N.
    Manly, Jennifer J.
    Marder, Karen S.
    Miller, Bruce L.
    Phelps, Creighton H.
    Seeley, William W.
    Sieber, Beth-Anne
    Silverberg, Nina B.
    Sutherland, Margaret
    Torborg, Christine L.
    Waddy, Salina P.
    Zlokovic, Berislav V.
    Corriveau, Roderick A.
    NEUROLOGY, 2014, 83 (09) : 851 - 860
  • [45] Editorial: Methods and applications in Alzheimer's disease and related dementias
    Yogi, Alvaro
    Grosso, Carlos Ayala
    FRONTIERS IN AGING NEUROSCIENCE, 2022, 14
  • [47] The Broad Range of Research in Alzheimer’s Disease and Related Dementias
    Steven T. DeKosky
    Ranjan Duara
    Neurotherapeutics, 2022, 19 : 1 - 7
  • [48] Alzheimer's disease and related dementias: important policy issues
    Stone, RI
    AGING & MENTAL HEALTH, 2001, 5 : S146 - S148
  • [49] Treatment and care strategies for Alzheimer's disease and related dementias
    Foerstl, H.
    NERVENARZT, 2008, 79 (05): : 617 - 628
  • [50] THE PRESCRIPTION DRUG LANDSCAPE OF ALZHEIMER'S DISEASE AND RELATED DEMENTIAS
    Bangerter, Lauren
    Clark, Callahan
    Jarvis, Megan
    Coates, Emma
    Sheils, Natalie
    Wong, Alyssa
    Cohen, Ken
    INNOVATION IN AGING, 2022, 6 : 468 - 468